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DockingAbstract Diospyros lotus is traditionally used in various diseases including inﬂammation. In the
current study an effort has been made to identify a bioactive constituent from D. lotus in order
to scientiﬁcally validate its use in inﬂammatory disorders. Diospyrin was isolated from D. lotus
and exhibited signiﬁcant lipoxygenase (LOX) inhibitory activity (IC50 value: 31.89 ± 0.14 lmol).
Molecular docking revealed signiﬁcant molecular interactions between Diospyrin and LOX show-
ing promising potential for further optimization as a potential anti-inﬂammatory lead compound.
ª 2013 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Genus Diospyros belongs to the family Ebenaceae which, con-
sists of woody shrubs and trees distributed in the tropical and
subtropical regions of the world. Around 500 species are known
worldwide of which, 24 species are native to India (Uddin et al.,
2011a). Diospyros lotus tree grows up to 9 m in height and
around 6 m in width. This plant is rarely available in Britainand it is native to the Himalayan region. In folk medicine,
Diospyros species are known for their multiple medicinal uses
in many traditional and folk medicinal systems all over the
world. All parts of these plants have been used for medicinal
purposes, which include its use for treatment of lumbago; pain,
fever, inﬂammation, and microbial infections. Diospyros spe-
cies are carminative, astringent, sedative and ferifuge (Pant
and Samant, 2010; Uddin et al., 2011a). Triterpenoids belong-
ing to lupane, oleanane and ursane series have been isolated
and showed anti-inﬂammatory activity (Uddin et al., 2011b).
Phytochemical studies have been previously carried out on
many Diospyros species and have revealed the widespread pres-
ence of naphthoquinones and naphthalene derivatives, dimeric
naphthoquinones and lupane triterpenes (Ahmad et al., 2010;
Uddin et al., 2011a). In the present study, a successful attempt
has been made regarding ethnopharmacological validation,
computational and experimental identiﬁcation of a potential
Figure 1 Chemical structure of Diospyrin.
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nase (LOX) inhibitor. LOX is one of the major therapeutic tar-
gets employed for the discovery of new anti-inﬂammatory
agents (Khan et al., 2011).
2. Experimental
2.1. Plant material
Roots of D. lotus were collected from Toormang Razagram,
Dir, KPK, Pakistan, in May 2009. The sample was authenti-
cated by Dr. Abdur Rashid, Taxonomist, Department of Bot-
any, University of Peshawar, Pakistan. A voucher specimen
(RF/01) has been deposited at the Herbarium, Department
of Botany, University of Peshawar, Pakistan.
2.2. Extraction and isolation
Shade-dried roots of D. lotus (14 kg) were powdered and then
kept at room temperature in MeOH for 6 days with continuous
stirring by simple percolation. After this period the extracts
were concentrated by evaporating solvents using a rotary vac-
uum evaporator under reduced pressure at temperature below
55 C. This process was repeated four times until the extraction
was completed and ﬁnally 202 g of dark green residue was
obtained. The MeOH extract (202 g) was suspended in water
and successively partitioned with hexane, CHCl3, EtOAc and
BuOH. The chloroform fraction (16 g) was subjected to
Column chromatography on silica gel (Merck Silica gel
60(0.063–0.200 mm), 5 · 60 cm). The column was ﬁrst eluted
with hexane–ethyl acetate (100:0ﬁ 0:100) as solvent system.
A total of 105 fractions, RF-1–RF-105 were obtained based
on TLC proﬁles. Elution of the chromatogram with Hexane–
Ethyl acetate (100:0ﬁ 10:100) gave a reddish oil of fatty acid
residues which is followed by 1.25 g of colorless needles that
were identiﬁed as lupeol (m.p. 210–212 C. Eluting the column
with hexane–ethyl acetate (100:0ﬁ 20:80) results in the
isolation of a violet red fraction and revealed two compounds
on TLC. This fraction was puriﬁed by preparative chromatog-
raphy which resulted in the isolation of a violet compound
(8-Hydroxyisodiospyrin) and 1H and 13CNMRdata were found
to be identical with those published by Baker et al. (1998). Frac-
tion RF-20 obtained at (100:0ﬁ 15:100) contained red crystals
of various sizes, shape and was separated from the solution by
washing with n-hexane. To obtain pure and larger crystals, these
crystals were re-grown from a mixture of hexane–chloroform
and thus obtained a polar orange–red crystalline compound
Diospyrin (m.p. 252–255 C) (1.4 g), 1H and 13CNMR data
were found to be identical to the data reported previously for
Diospyrin (Yoshida and Mori, 2000).
3. Molecular docking simulations
FRED 2.1 (McGann et al., 2003; Khan et al., 2009) was used
in this study to dock the OMEGA pre-generated multi-
conformer library mentioned above. FRED 2.1 strategy is to
exhaustively dock/score all possible positions of each ligand
in the binding site. The exhaustive search is based on rigid
rotations and translations of each conformer within the bind-
ing site deﬁned by a box. FRED ﬁltered the poses ensemble by
rejecting the ones that clash with the protein (LOX) or thatdoes not have enough contacts with the protein. The ﬁnal
poses can then be scored or re-scored using one or more scor-
ing functions. In this study, the smooth shape-based Gaussian
scoring function (shapegauss) was selected to evaluate the
shape complementarily between each ligand and the binding
pocket. Default FRED protocol was used except for the size
of the box deﬁning the binding sites. In an attempt to optimize
the docking-scoring performance we performed exhaustive
docking with shapegauss applying the ‘‘Optimization’’ mode.
The ‘‘Optimization’’ mode involves a systematic solid body
optimization of the top ranked poses from the exhaustive
docking. Three different boxes were explored for LOX (PDB
ID: 1JNQ). Three different simulations were carried out with
an added value of 8 A˚ around the reference ligand.
4. In vitro lipoxygenase inhibition assay
Enzyme inhibition assays were performed by using different
concentrations of the isolated compound Diospyrin (Nisar
et al., 2011). Lipoxygenase inhibitory activity was measured
by slightly modifying the spectrometric method as developed
by Lipoxygenase (EC 1.13.11.12) type I-B (Soybean) and lino-
leic acid were purchased from Sigma (St. Louis, MO) and were
used without further puriﬁcation. All other chemicals were of
analytical grade and purchased from the same vendor i.e. Sig-
ma (St. Louis, MO). 160 lL of sodium phosphate buffer,
0.1 mM (pH 7.0), 10 mL of the sample solutions (test com-
pound and standards) and 20 lL of lipoxygenase solution were
mixed and incubated for 5 min at 258 C. Reaction was initi-
ated by the addition of 10 lL linoleic acid substrate solution
and absorption change with the formation of (9Z,11E)-13S)-
13-hydroperoxyo-ctadeca-9,11-dienoate was followed for
10 min. Test sample and control were dissolved in 50% etha-
nol. All the reactions were performed in triplicate. Baicalein
and Tenidap sodium were used as positive controls for lipoxy-
genase inhibition (Khan et al., 2009). The IC50 values were cal-
culated using the EZFit Enzyme Kinetics program (Perrella
Scientiﬁc Inc., Amherst, USA).
5. Results and discussion
5.1. In vitro lipoxygenase inhibition assay
All compounds showed promising inhibitory activity against
lipoxygenase. IC50 value of Diospyrin (Fig. 1) was 62.7 ±
0.12. Standard compounds Baicalein and Tenidap sodium
showed the IC50 value being 22.1 ± 0.03 lM and 41.6 ±
0.02 lM respectively.
Figure 3 Electrostatic interactions of Diospyrin inside the active
site of LOX. Color encoding (White area: hydrophobic region, red
area: area with aggregated negative electrostatic potential, and
blue area: area with aggregated positive electrostatic potential).
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Structural insights based on molecular docking revealed impor-
tant subsites essentially required to be interacting with LOX
inhibitors for new drug discovery of new LOX inhibitors.
Among these especially between His523, Lle554 and Leo773
Diospyrin exhibited signiﬁcant interactions with important sub-
sites inside catalytic pocket of LOX. Molecular shape and elec-
trostatic condition of diospyrin were also identiﬁed to be
favorably matched with the electrostatic environment of active
site inside LOX. Various molecular interactions were observed
between the test ligand and LOX. Hydrogen bonding (Fig. 2)
was found between His 518 (2.55 A˚) and carbonyl oxygen of
quinine moiety. This interaction was further reinforced by
hydrogen bonding between Asp 766 (2.79 A˚) and phenolic
group. However molecular shape of the compound, Diospyrin
was incapable to access Ile857 and His 709. Apart from hydro-
gen bonding, electrostatic environment (Fig. 3) of active site in
LOX further supported the signiﬁcant molecular interactions of
Diospyrin due to its matching shape and electrostatic behavior.
Other interactions like p–p interactions between ligand and
LOX inside the active site monomer (not bound via hydrogen
bonding) of Diospyrin was deeply penetrated inside slightly less
polar cavity surrounded by aggregated positive charges. Rotat-
able bond between both anthraquinone dimmers provided ﬂex-
ibility to diospyrin for penetrating the active site with small
pockets by directing in different directions.
Lipoxygenase (EC 1.13.11.12) constitutes a family of non-
heme iron containing enzymes, as versatile biocatalysts are
capable of catalyzing many reactions involved in the xenobiotic
metabolism. They are responsible for the metabolism of the
fatty acids (FAs) and their metabolites eliciting inﬂammatory
responses in the body. They also play a signiﬁcant role in cancer
cell growth, metastasis, invasiveness, cell survival and induction
of tumor necrosis factor (TNF) (Arfan et al., 2010). Many
COX-2 or 5-LOX inhibitors have been developed as drugs to
treat inﬂammation (Nisar et al., 2011). In this study, diospyrin
exhibited a signiﬁcant inhibition of the lipoxygenase showing
its strong potential to be developed as an anti-inﬂammatory
drug. Molecular docking studies revealed that its compact skel-
eton is the basic reason of how it holds strong contacts with the
important amino acid side chains inside the active site as well asFigure 2 Binding mode of Diospyrin inside the active site of
LOX. Catalytic iron atom (orange colored) is shown between the
His518 and Ile 770 residues. Hydrogen atoms (except polar ones)
were omitted for clarity.adjoining sites of the enzyme thus preventing its pro-inﬂammatory
role. In the current study Diospyrin exhibited strong molecular
interactions which ultimately resulted in discovery of Disoprin
made a potential new lead compound targeting LOX in inﬂam-
mation and related pathological conditions.
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